Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/48626
XPO1 INHIBITORS REPRESENT A NOVEL THERAPEUTIC OPTION IN ADULT T-CELL LEUKEMIA, TRIGGERING P53- MEDIATED CASPASE-DEPENDENT APOPTOSIS
Linfoma Difuso de Grandes Células B
Neoplasias
Vírus Linfotrópico T Tipo 1 Humano
Author
Affilliation
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, B-3000. Leuven, Belgium.
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, B-3000. Leuven, Belgium.
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute, B-3000. Leuven, Belgium.
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute, B-3000. Leuven, Belgium.
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, B-3000. Leuven, Belgium.
Karyopharm Therapeutics. Newton, MA, USA.
Karyopharm Therapeutics. Newton, MA, USA.
Oswaldo Cruz Foundation. Instituto de Pesquisa Gonçalo Moniz. Salvador, BA, Brazil.
Federal University of Bahia. HUPES. Salvador, BA, Brazil.
Kyoto University. Department of Pathology and Tumor Biology. Kyoto, Japan. .
Kyoto University. Department of Pathology and Tumor Biology. Kyoto, Japan.
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, B-3000. Leuven, Belgium.
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, B-3000. Leuven, Belgium.
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute, B-3000. Leuven, Belgium.
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, B-3000. Leuven, Belgium.
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, B-3000. Leuven, Belgium.
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute, B-3000. Leuven, Belgium.
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute, B-3000. Leuven, Belgium.
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, B-3000. Leuven, Belgium.
Karyopharm Therapeutics. Newton, MA, USA.
Karyopharm Therapeutics. Newton, MA, USA.
Oswaldo Cruz Foundation. Instituto de Pesquisa Gonçalo Moniz. Salvador, BA, Brazil.
Federal University of Bahia. HUPES. Salvador, BA, Brazil.
Kyoto University. Department of Pathology and Tumor Biology. Kyoto, Japan. .
Kyoto University. Department of Pathology and Tumor Biology. Kyoto, Japan.
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, B-3000. Leuven, Belgium.
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, B-3000. Leuven, Belgium.
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute, B-3000. Leuven, Belgium.
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, B-3000. Leuven, Belgium.
Keywords in Portuguese
Leucemia de Células TLinfoma Difuso de Grandes Células B
Neoplasias
Vírus Linfotrópico T Tipo 1 Humano
Share